MyFinsight
Home
Blog
About
Cash and cash
equivalents
$26,271,650
Short-term investments
$11,409,607
Prepaid expenses and
other current assets,...
$1,758,348
Total current assets
$39,439,605
Operating lease
right-of-use assets
$6,114,303
Fixed assets, net
$2,210,759
Other assets
$2,012,475
Total assets
$49,777,142
Total liabilities and
stockholders equity
$49,777,142
Total liabilities
$43,709,260
Total inovio
pharmaceuticals, inc....
$6,067,882
Accumulated deficit
-$1,834,847,961
Accumulated other
comprehensive loss
-$636,093
Total current
liabilities
$37,923,025
Operating lease
liability, net of current...
$5,786,235
Additional paid-in capital
$1,841,482,163
Common stock
$69,773
Common stock warrant
liabilities
$24,929,459
Accounts payable and
accrued...
$9,267,415
Operating lease liability
$2,908,820
Accrued clinical trial
expenses
$817,331
Back
Back
Balance Sheet
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)
source: myfinsight.com